Migraine frequency Number of attacks · patients with Raynaud's phenomenon
1 finding from 1 review
Duration of attacks · patients with Raynaud's phenomenon
1 finding from 1 review
Severity of attacks · patients with Raynaud's phenomenon
1 finding from 1 review
Pain intensity (0‐10cm visual analogue scale) · patients with Raynaud's phenomenon
1 finding from 1 review
Patient global Disability due to Raynaud's assessed on a 10‐cm visual analogue scale (0 = no disability, 10 = maximal disability) · patients with Raynaud's phenomenon
1 finding from 1 review
Withdrawals due to adverse events · patients with Raynaud's phenomenon
Calcium channel blockers showed no clear difference in number of withdrawals due to adverse events Number of participants… compared with placebo (low certainty).
1 finding from 1 review
Serious adverse events Number of participants who died or withdrew and were hospitalized as a result of adverse effects of treatment · patients with Raynaud's phenomenon
1 finding from 1 review
Death · kidney transplant recipients
Calcium channel blockers showed no clear difference in death compared with placebo/no treatment (low certainty).
1 finding from 1 review
Graft loss · kidney transplant recipients
Calcium channel blockers may leads to lower graft loss compared with placebo/no treatment (low certainty).
1 finding from 1 review
GFR · kidney transplant recipients
1 finding from 1 review
Acute rejection · kidney transplant recipients
Calcium channel blockers showed no clear difference in acute rejection compared with placebo/no treatment (low certainty).
1 finding from 1 review
Discontinuation of treatment due to side effects ( · kidney transplant recipients
Calcium channel blockers showed no clear difference in withdrawal due to side effects compared with placebo/no treatment (low certainty).
1 finding from 1 review
Proteinuria · kidney transplant recipients
1 finding from 1 review
Blood pressure · kidney transplant recipients
1 finding from 1 review
Predialysis systolic blood pressure · people with CKD requiring dialysis
1 finding from 1 review
Diastolic blood pressure · people with CKD requiring dialysis
1 finding from 1 review
Cardiovascular mortality · people with CKD requiring dialysis
1 finding from 1 review
Intradialytic hypotension · people with CKD requiring dialysis
Dihydropyridine calcium channel blockers showed no clear difference in intradialytic hypotension compared with placebo/control (low certainty).
1 finding from 1 review
Other side effects · people with CKD requiring dialysis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Variation in the decrease in 24‐hour ambulatory hourly SBP (at 3 to 12 weeks) · adults with primary hypertension
1 finding from 1 review